January 10, 2023
To,
Listing Department,
National Stock Exchange of India Limited
Exchange Plaza, Plot No C-1, Block G, Bandra Kurla Complex,
Bandra (E), Mumbai - 400051
NSE Symbol: BALAXI
Subject: Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the period ended December 31, 2022.
Dear Sir/Madam,
In terms of the provisions of Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we enclose herewith copy of the certificate received from Aarthi Consultants Private Limited, the Registrar and Share Transfer Agent of the Company for the period ended December 31, 2022.
This is for your information and records.
Yours Faithfully,
For Balaxi Pharmaceuticals Limited
Digitally signed
Udayan by Udayan
Shukla
Shukla Date: 2023.01.10 12:08:06 +05'30'
Udayan Shukla
(Company Secretary & Compliance Officer)
Membership No.: F11744
Encl: As above
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Balaxi Pharmaceuticals Ltd. published this content on 10 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 January 2023 07:16:12 UTC.